High income vs Naoero: Immunization, DPT
High income
94.2%
in 2024
Naoero
99.0%
in 2024
High income rank
4th
Naoero rank
1st
Immunization, DPT over time
- High income
- Naoero
How they compare
Naoero currently reports 99.0% against 94.2% in High income, a difference of 4.8%.
That makes Naoero's figure about 1.1 times High income's.
The two have swapped places 7 times across 41 shared years of data; in 1984 it was High income ahead.
High income ranks 4th and Naoero ranks 1st of 47 groups.
Across the 5 decades both report, High income averaged higher in 4 and Naoero in 1.
Head to head by decade
| Decade | High income | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 82.7% | 65.3% | 17.4% | High income |
| 1990s | 89.9% | 62.9% | 27.0% | High income |
| 2000s | 95.4% | 82.8% | 12.6% | High income |
| 2010s | 95.3% | 92.0% | 3.3% | High income |
| 2020s | 94.4% | 98.0% | 3.6% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, dpt, High income or Naoero?
- Naoero, at 99.0% against 94.2% in High income as of 2024.
- What is the difference in immunization, dpt between High income and Naoero?
- 4.8%, with Naoero ahead.
- How many years of comparable data are there for High income and Naoero?
- 41 years are reported by both, from 1984 to 2024.
- How do High income and Naoero rank globally for immunization, dpt?
- High income ranks 4th and Naoero ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, DPT (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.